Ibn Al Haytham Hospital Faces Financial Challenges Amid Quality Score Downgrade

Ibn Al Haytham Hospital Co. has recently undergone an evaluation adjustment, reflecting notable shifts in its financial metrics. The company, operating within the hospital industry, has experienced a revision in its quality score, now categorized as below average. This change is attributed to various factors, including a decline in sales growth over the past five years, which stands at -1.10%, and a significant drop in EBIT growth of -34.92%. Additionally, the company's return on capital employed (ROCE) and return on equity (ROE) are relatively low, at 2.02% and 1.68%, respectively. On the valuation front, the stock has been assessed as expensive, with key metrics such as the EV to EBIT ratio at 9.27 and EV to EBITDA at 6.75. The company's price-to-book value remains at 0.00, indicating a high valuation relative to its book value. Despite a positive financial performance in the quarter ending December 2025, the stock has underperformed compared to the broader market, generating a return of 14.49% over the past year, which is significantly lower than the Jordan General Index's return of 37.82%. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.